Cases of the “deadly” monkeypox virus are spreading in Africa. Many of the Asian nations impacted are ramping up their border control as the ruling classes continue to issue fear-mongering warnings.
Following the detection of a potentially more dangerous variant, many Asian countries are proceeding with protocols similar to those that were imposed during the COVID-19 scamdemic. Thailand has reported its first suspected case of the new clade 1b variant, prompting “swift action” from regional ruling health “authorities.”
Ruling health officials said plans (orders) are underway to tackle a possible outbreak in the country ensuring healthcare workers are aware of the symptoms and that rapid tests are available, according to a report by The Independent UK.
So far, most European countries have not imposed strict border controls. However, in Argentina, a cargo ship was quarantined over the first suspected case of mpox on the vessel, after one of its crew members showed “cyst-like skin lesions”, the health ministry said.
Oddly enough, or coincidentally, there is a mpox “vaccine” at the ready.
Shares of Danish biotech Bavarian Nordic surged following robust earnings and a significant order of its mpox vaccine.
US firm Emergent BioSolutions saw its shares jump nearly 10 percent yesterday.
The mpox outbreak, primarly affecting the Democratic Republic of Congo has prompted international concern with countries pilling up vaccines for a potential outbreak.
The World Health Organisation (WHO) and Africa CDC have both issued public health emergencies as the virus spreads to more than a dozen countries.
The WHO has reported over 17,000 cases and more than 500 deaths this year. –The Independent UK
A World Health Organisation official stressed on Tuesday that mpox, regardless of whether it is the new or old strain, is not the new COVID, as authorities know how to control its spread.
WHO Declares Mpox A Global Public Health Emergency
About 100 new cases of the clade 2 mpox strain are now being reported in the European region every month, said Hans Kluge, the WHO’s regional director for Europe.
